Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?

e-ESO Podcasts - Un podcast de ESO - European School of Oncology

Catégories:

Expert: Luiza Weis, Cancer Institute of Brasilia - ICB, Brasília, Brazil

Visit the podcast's native language site